Filing metadata

Accession number
0001415889-25-008359
Form type
Form 4
Filer
Stoke Therapeutics, Inc.
CIK
CIK 1623526
Filed
Mar 18, 2025
Reporting period
Mar 15, 2025
Description
Insider transaction

Explore SEC Filings Hub

4 | SEC Filings Hub